What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Publication Nov 6, 2024
Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Christopher Ma, Vipul Jairath, Virginia Salitano

Publication May 10, 2021
Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators

Christopher Ma, Vipul Jairath

Publication May 10, 2021
Methods for Handling Missing Segments in Crohn’s Disease Clinical Trials: Analysis From the EXTEND Trial

Brian Feagan, Christopher Ma, Guangyong Zou, Vipul Jairath

Publication May 10, 2021
Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review

Brian Feagan, Christopher Ma, Niels Vande Casteele, Vipul Jairath

Publication May 10, 2021
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials

Christopher Ma, Niels Vande Casteele, Vipul Jairath

Publication May 10, 2021
Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis

Brian Feagan, Christopher Ma, Geert D’Haens, Vipul Jairath

Publication May 10, 2021
An Expert Consensus to Standardise Clinical, Endoscopic and Histologic Items and Inclusion and Outcome Criteria for Evaluation of Pouchitis Disease Activity in Clinical Trials

Brian Feagan, Vipul Jairath